Company Registration No. SC470876 (Scotland)
Forbes Clinical Monitoring Limited
Unaudited accounts
for the year ended 30 June 2024
Forbes Clinical Monitoring Limited
Statement of financial position
as at 30 June 2024
Cash at bank and in hand
25,197
54,169
Creditors: amounts falling due within one year
(27,846)
(34,349)
Net current assets
8,847
19,820
Total assets less current liabilities
9,376
20,615
Creditors: amounts falling due after more than one year
(8,870)
(11,970)
Called up share capital
10
10
Profit and loss account
496
8,635
Shareholders' funds
506
8,645
For the year ending 30 June 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 28 February 2025 and were signed on its behalf by
Karen Anne Forbes
Director
Company Registration No. SC470876
Forbes Clinical Monitoring Limited
Notes to the Accounts
for the year ended 30 June 2024
Forbes Clinical Monitoring Limited is a private company, limited by shares, registered in Scotland, registration number SC470876. The registered office is Redbrae, Main Street, Gavinton, Duns, TD11 3QT.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
These financial statements for the year ended 30 June 2024 are the first financial statements that comply with FRS 102 Section 1A Small Entities. The date of transition is 1 July 2022.
The transition to FRS 102 Section 1A Small Entities has resulted in a small number of changes in accounting policies to those used previously.
The nature of these changes and their impact on opening equity and profit for the comparative period are explained in the notes below.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Fixtures & fittings
over 5 years useful life
4
Tangible fixed assets
Plant & machinery
Computer equipment
Total
Cost or valuation
At cost
At cost
At 1 July 2023
3,380
3,483
6,863
At 30 June 2024
3,380
3,483
6,863
At 1 July 2023
3,380
2,688
6,068
Charge for the year
-
266
266
At 30 June 2024
3,380
2,954
6,334
Forbes Clinical Monitoring Limited
Notes to the Accounts
for the year ended 30 June 2024
Amounts falling due within one year
6
Creditors: amounts falling due within one year
2024
2023
Taxes and social security
4,252
2,768
Loans from directors
22,759
1,231
7
Creditors: amounts falling due after more than one year
2024
2023
Taxes and social security
12
12
8
Average number of employees
During the year the average number of employees was 2 (2023: 2).